Jose F Rodriguez-Palomares
Overview
Explore the profile of Jose F Rodriguez-Palomares including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
954
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Palomares J, Olivero R, Teixido-Tura G
Eur J Prev Cardiol
. 2025 Feb;
PMID: 39968766
No abstract available.
2.
Alonso A, Sambola A, Valente F, Sao A, Rodenas-Alesina E, Rello P, et al.
Eur Heart J Cardiovasc Imaging
. 2025 Feb;
PMID: 39928570
Aims: The impact of sex on adverse left ventricular remodeling (LVR) after ST-elevation myocardial infarction (STEMI) is unclear due to conflicting results. This study sought to establish sex-based differences in...
3.
Casas G, Rodenas-Alesina E, Limeres J, Badia-Molins C, Larranaga-Moreira J, Mirelis J, et al.
Rev Esp Cardiol (Engl Ed)
. 2025 Feb;
PMID: 39920987
Introduction And Objectives: Defining the probability of cardiomyopathy in individuals with excessive trabeculation of the left ventricle (ETLV) is an unmet clinical need. Our aims were: a) to describe the...
4.
Leo I, Dellegrottaglie S, Scatteia A, Torella D, Abete R, Aquaro G, et al.
Eur Heart J Cardiovasc Imaging
. 2025 Feb;
PMID: 39899463
Background: Accurate risk stratification for patients with non-dilated left ventricular cardiomyopathy (NDLVC) remains challenging due to lack of dedicated clinical trials. This post-hoc analysis aims to delineate the arrhythmic risk...
5.
Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al.
G Ital Cardiol (Rome)
. 2025 Jan;
26(1 Suppl 1):e1-e169.
PMID: 39820078
No abstract available.
6.
Shiwani H, Davies R, Topriceanu C, Ditaranto R, Owens A, Raman B, et al.
J Am Coll Cardiol
. 2025 Jan;
85(7):685-695.
PMID: 39772357
Background: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death. Current diagnosis emphasizes the detection of left ventricular hypertrophy (LVH) using a fixed threshold of ≥15-mm maximum wall...
7.
AlAref S, Gautam N, Mansour M, Alqaisi O, Tarun T, Devabhaktuni S, et al.
Int J Cardiol
. 2024 Nov;
419:132709.
PMID: 39515617
Aims: While factors associated with adverse events are well elucidated in setting of isolated left ventricular dysfunction, clinical and imaging-based prognosticators of adverse outcomes are lacking in context of biventricular...
8.
Bertolin-Boronat C, Marcos-Garces V, Merenciano-Gonzalez H, Perez N, Perez Del Villar C, Gavara J, et al.
Eur J Intern Med
. 2024 Oct;
131:104-112.
PMID: 39384454
Background: Left ventricular thrombus (LVTh) is a severe complication after ST-segment elevation myocardial infarction (STEMI). Objectives: We aim to predict LVTh occurrence by cardiac magnetic resonance (CMR) using clinical, echocardiographic,...
9.
Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al.
Eur Heart J
. 2024 Aug;
45(36):3538-3700.
PMID: 39210722
No abstract available.
10.
Solsona-Caravaca J, Fernandez-Galera R, Gonzalez-Fernandez V, Airale L, Rivas J, Scudeler L, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200177
Background: Longitudinal data on reverse cardiac remodeling and outcomes after transcatheter edge-to-edge repair (TEER) are limited. Methods: A total of 78 patients with severe mitral regurgitation (MR) were included retrospectively....